Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

55.90 +0.75 (+1.36%)
Official Closing Price Updated: 7:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,946,132
Open 55.22
Bid (Size) 55.83 (1)
Ask (Size) 56.10 (4)
Prev. Close 55.15
Today's Range 54.96 - 56.43
52wk Range 53.70 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 4.33%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
These highly advantaged businesses have what they need to keep raising their dividend payouts. 
Via The Motley Fool
CVS Health Unusual Options Activity
Via Benzinga

Performance

YTD
-30.86%
-30.86%
1 Month
-25.07%
-25.07%
3 Month
-23.52%
-23.52%
6 Month
-20.43%
-20.43%
1 Year
-18.74%
-18.74%

More News

Read More
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Expert Outlook: CVS Health Through The Eyes Of 11 Analysts
Via Benzinga
CVS Is Sick
Via Talk Markets
Why CVS Health Stock Plunged Today
Via The Motley Fool
The Law Offices of Frank R. Cruz Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
From Schall Law
Via GlobeNewswire
Unpacking the Latest Options Trading Trends in CVS Health
Via Benzinga
CVS Health (CVS) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Moody’s, Booking, DraftKings, Amgen Stocks In Focus Ahead Of Earnings
Via Talk Markets
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
CVS Shares Dump On Earnings Miss, Outlook Slashed On Rising Medical Costs
Via Talk Markets
Topics Earnings
Exposures Financial
CVS Stock Earnings: CVS Health Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Rising Cost For Health Insurers Bites CVS Health's Q1 Profit, Stock Tanks
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CVS Health Dives To 3-Year Low On Medicare Cost Surge
Via Investor's Business Daily
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
Via MarketBeat
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
Via Benzinga
Topics Economy
Exposures Interest Rates
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
Via MarketBeat
Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC?
Via Investor's Business Daily
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.